| |
| |
|
| Insider
Information: |
Opaleye Management Inc. |
| Relationship: |
10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
11,357,063 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$69,327,006 |
|
|
| Total
Shares |
11,357,063 |
|
|
| Total
Value |
$69,327,006 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
123
|
8
|
|
Stock
price went up :
|
64
|
1
|
| Stock
price went down : |
59
|
7
|
| |
|
|
|
Gain/Loss Ratio : |
1.1
|
1.1
|
| Percentage
Gain/Loss : |
 15.1%
|
 -143.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Harrow Health Inc |
HROW |
10% Owner |
2015-05-19 |
0 |
2024-04-25 |
3,815,000 |
Premium* |
|
|
Ocular Therapeutix, Inc |
OCUL |
10% Owner |
|
0 |
2020-01-02 |
4,918,500 |
Premium* |
|
|
Eton Pharmaceuticals, Inc. |
ETON |
10% Owner |
|
0 |
2021-11-17 |
2,375,000 |
Premium* |
|
|
Tracon Pharmaceuticals, Inc. |
TCON |
10% Owner |
2020-08-27 |
0 |
2023-11-10 |
0 |
Premium* |
|
|
Protara Therapeutics, Inc |
TARA |
10% Owner |
2020-09-24 |
0 |
2024-05-22 |
123,750 |
Premium* |
|
|
Tela Bio, Inc. |
TELA |
10% Owner |
2022-06-10 |
0 |
2022-11-03 |
124,813 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
160 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OCUL |
Ocular Therapeutix, Inc |
10% Owner |
– – • |
2019-12-30 |
4 |
B |
$3.97 |
$79,410 |
I/I |
20,000 |
207,500 |
1.5 |
- |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2020-09-01 |
4 |
B |
$2.04 |
$81,768 |
I/I |
40,000 |
1,540,946 |
1.5 |
% |
|
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2022-07-21 |
4 |
B |
$8.03 |
$83,010 |
I/I |
10,333 |
100,000 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2024-04-24 |
4 |
B |
$10.15 |
$84,093 |
I/I |
8,285 |
3,795,000 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2020-12-22 |
4 |
B |
$5.19 |
$86,010 |
I/I |
16,557 |
136,016 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2023-09-20 |
4 |
B |
$14.49 |
$86,710 |
I/I |
5,983 |
3,620,000 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2022-04-13 |
4 |
B |
$6.76 |
$86,785 |
I/I |
12,832 |
157,732 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2021-06-17 |
4 |
B |
$8.32 |
$93,701 |
I/I |
11,262 |
136,478 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2022-04-22 |
4 |
B |
$2.24 |
$93,941 |
I/I |
42,000 |
334,337 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2024-05-09 |
4 |
S |
$3.09 |
$94,526 |
I/I |
(30,600) |
2,531,994 |
0 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2020-09-24 |
4 |
B |
$4.44 |
$95,648 |
I/I |
21,534 |
1,785,438 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2024-05-21 |
4 |
S |
$3.06 |
$100,838 |
I/I |
(33,000) |
124,250 |
0 |
% |
|
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2022-08-10 |
4 |
B |
$8.52 |
$102,089 |
I/I |
11,979 |
105,000 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2020-07-12 |
4 |
B |
$4.98 |
$104,246 |
I/I |
20,900 |
131,900 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2021-11-18 |
4 |
B |
$6.98 |
$106,130 |
I/I |
15,206 |
102,647 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2021-12-14 |
4 |
B |
$2.53 |
$106,344 |
I/I |
42,000 |
250,711 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2020-08-28 |
4 |
B |
$1.78 |
$106,974 |
I/I |
60,000 |
210,000 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2022-09-28 |
4 |
B |
$9.77 |
$108,354 |
I/I |
11,085 |
158,817 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2020-06-02 |
4 |
B |
$5.69 |
$110,339 |
I/I |
19,400 |
2,519,400 |
1.5 |
% |
|
| ETON |
Eton Pharmaceuticals, Inc... |
10% Owner |
– – • |
2021-11-17 |
4 |
S |
$4.67 |
$116,713 |
I/I |
(25,000) |
2,375,000 |
0 |
- |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2020-06-03 |
4 |
B |
$5.74 |
$118,308 |
I/I |
20,600 |
2,540,000 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2022-01-28 |
4 |
B |
$4.96 |
$119,271 |
I/I |
24,031 |
124,031 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2021-12-01 |
4 |
B |
$2.40 |
$120,160 |
I/I |
50,000 |
230,000 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2024-04-23 |
4 |
B |
$10.29 |
$120,547 |
I/I |
11,715 |
3,786,715 |
1.5 |
% |
|
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2022-10-11 |
4 |
B |
$8.00 |
$128,000 |
I/I |
16,000 |
123,551 |
1.5 |
% |
|
160 Records found
|
|
Page 4 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
